CUMYL-NBMINACA explained

CUMYL-NBMINACA (SGT-152, Cumyl-BC[2.2.1]HpMINACA) is a synthetic cannabinoid compound first reported in a 2013 patent,[1] but not identified as a designer drug until 2021, being identified by a forensic laboratory in Germany in February 2021.[2] [3]

See also

Notes and References

  1. Cannabinoid compounds . WO . 2014167530 . 11 April 2013 . Bowden MJ, Williamson PB .
  2. Pulver B, Riedel J, Schönberger T, Pütz M, Schäper J, Kunert N, Putzer K, Hermann G, Auwärter V, Westphal F . 6 . Comprehensive structural characterisation of the newly emerged synthetic cannabimimetics Cumyl-BC [2.2. 1] HpMeGaClone, Cumyl-BC [2.2. 1] HpMINACA, and Cumyl-BC [2.2. 1] HpMICA featuring a norbornyl methyl side chain. . Forensic Chemistry . December 2021 . 26 . 100371 . 10.1016/j.forc.2021.100371 . 243179410 .
  3. Web site: New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System . June 2022 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "CUMYL-NBMINACA".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.